loading . . . QIAGEN to acquire Parse Biosciences, expanding its Sample technologies portfolio into highly scalable single-cell solutions Parse Biosciences is a fast-growing innovator in single-cell sample preparation, with technologies used in more than 3,000 labs across over 40 countries Acquisition strengthens QIAGEN’s presence in… https://corporate.qiagen.com/English/newsroom/press-releases/press-release-details/2025/QIAGEN-to-acquire-Parse-Biosciences-expanding-its-Sample-technologies-portfolio-into-highly-scalable-single-cell-solutions/default.aspx
